Because GH resistance at least partially resolves in the chronic phase, it is likely that such high doses of GH and, consequently, high levels of IGF-I, evoke toxic side effects, such as excessive fluid retention, hypercalcemia, and pronounced insulin resistance with hyperglycemia. The gene discussed is GH1; the disease is Hyperglycemia.